{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:14:22Z","timestamp":1762866862426},"reference-count":0,"publisher":"Portico","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2016.52.3.2440527","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T05:02:35Z","timestamp":1462251755000},"page":"183","source":"Crossref","is-referenced-by-count":22,"title":["PCSK9 inhibitors: monoclonal antibodies for the treatment of\nhypercholesterolemia"],"prefix":"10.3730","volume":"52","author":[{"family":"Paton, D.M.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2016]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:09:55Z","timestamp":1685452195000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddkvr2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2016.52.3.2440527","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}